Provides the dose transition pathways (DTP) to project in advance the doses recommended by a model-based design for subsequent patients (stay, escalate, deescalate or stop early) using all the accumulated toxicity information; See Yap et al (2017) <doi:10.1158/1078-0432.CCR-17-0582>. DTP can be used as a design and an operational tool and can be displayed as a table or flow diagram. The 'dtpcrm' package also provides the modified continual reassessment method (CRM) and time-to-event CRM (TITE-CRM) with added practical considerations to allow stopping early when there is sufficient evidence that the lowest dose is too toxic and/or there is a sufficient number of patients dosed at the maximum tolerated dose.
Version: | 0.1.1 |
Imports: | diagram, dfcrm |
Suggests: | knitr, rmarkdown, testthat |
Published: | 2019-08-20 |
Author: | Christina Yap [aut, cre], Daniel Slade [aut], Kristian Brock [aut], Yi Pan [aut] |
Maintainer: | Christina Yap <yapchristina17 at gmail.com> |
License: | GPL-2 | GPL-3 [expanded from: GPL (≥ 2)] |
NeedsCompilation: | no |
CRAN checks: | dtpcrm results |
Reference manual: | dtpcrm.pdf |
Vignettes: |
dtpcrm: Dose Transition Pathways with Continual Reassessment Method |
Package source: | dtpcrm_0.1.1.tar.gz |
Windows binaries: | r-devel: dtpcrm_0.1.1.zip, r-release: dtpcrm_0.1.1.zip, r-oldrel: dtpcrm_0.1.1.zip |
macOS binaries: | r-release: dtpcrm_0.1.1.tgz, r-oldrel: dtpcrm_0.1.1.tgz |
Old sources: | dtpcrm archive |
Please use the canonical form https://CRAN.R-project.org/package=dtpcrm to link to this page.